# SGS France – FDA Inspection, Jan 19, 2024

Source: https://www.keypedia.com/records/fda_inspections/sgs-france/2068e554-0de4-4dd8-b6b9-500110785aee
Source feed: FDA_Inspections

> FDA inspection 1275370 of SGS France, January 19, 2024. Classification: Voluntary Action Indicated (VAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1275370
- Company Name: SGS France
- Inspection Date: 2024-01-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1062705 - 2018-06-22
- FDA Inspection 945927 - 2015-09-17
- FDA Inspection 841077 - 2013-06-20
- FDA Inspection 631854 - 2009-10-29

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/mra-v-millarw/ea28ecad-65ef-4cbe-9f4b-fa460dcef90f)

Company: https://www.keypedia.com/companies/sgs-france/e79e59a7-31e7-4536-94ef-f3cdc0fa4c12

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c